CR
NASDAQ · CRDL
Cardiol Therapeutics Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$2.00
Up+$0.02 (+0.76%)
Updated Sep 12, 2026, 5:54 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 94.81M
- P/E ratio
- -3.26
- Dividend yield
- 0.00%
- 52-week range
- $0.90 – $2.34
- Volume
- 1.24M
- Avg. volume
- 704.06K
Price performance
CRDL price history
1M range · 20 trading sessions · Daily adjusted prices
CRDL closed at $2.00 after 20 trading sessions, up 10.83% for the selected period.
- Last close
- $2.00
- Period change
- +10.83%
- Period low
- $1.80
- Period high
- $2.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $2.03 | $2.0779 | $1.945 | $1.995 | 1.24M |
| Sep 10, 2026 | $2.21 | $2.24 | $1.975 | $1.98 | 1.78M |
| Sep 9, 2026 | $2.22 | $2.34 | $2.21 | $2.285 | 1.97M |
| Sep 8, 2026 | $2.20 | $2.24 | $2.16 | $2.22 | 1.24M |
| Sep 4, 2026 | $2.16 | $2.2191 | $2.12 | $2.20 | 1.1M |
| Sep 3, 2026 | $2.18 | $2.20 | $2.085 | $2.16 | 976.67K |
| Sep 2, 2026 | $2.16 | $2.235 | $2.095 | $2.17 | 2.18M |
| Sep 1, 2026 | $1.94 | $2.19 | $1.93 | $2.15 | 2.12M |
| Aug 31, 2026 | $1.92 | $1.98 | $1.88 | $1.975 | 780.88K |
| Aug 28, 2026 | $2.06 | $2.1129 | $1.90 | $1.94 | 1.66M |
| Aug 27, 2026 | $2.09 | $2.17 | $2.035 | $2.06 | 1.84M |
| Aug 26, 2026 | $2.03 | $2.275 | $2.01 | $2.14 | 4.53M |
| Aug 25, 2026 | $1.89 | $2.02 | $1.86 | $2.00 | 2.17M |
| Aug 24, 2026 | $1.88 | $1.88 | $1.7608 | $1.86 | 1.01M |
| Aug 21, 2026 | $1.93 | $1.9319 | $1.855 | $1.86 | 753.35K |
| Aug 20, 2026 | $1.96 | $1.995 | $1.83 | $1.885 | 1.53M |
| Aug 19, 2026 | $1.92 | $1.965 | $1.86 | $1.96 | 1.75M |
| Aug 18, 2026 | $1.82 | $1.90 | $1.735 | $1.895 | 1.6M |
| Aug 17, 2026 | $1.73 | $1.94 | $1.73 | $1.80 | 2.33M |
| Aug 14, 2026 | $1.73 | $1.82 | $1.65 | $1.80 | 1.73M |
Latest CRDL news
The latest Smart Investors Daily articles mentioning CRDL.
Stock researchResearch & News · Competitors
Loading stock research…
